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Background: Primary idiopathic chylopericardium is a rare clinical entity characterized by the accumulation of
chyle within the pericardial cavity without a definitive cause. The aim of this study was to assess the clinical
presentation, etiology, diagnosis, treatment and follow-up of primary idiopathic chylopericardium.
Methods: We retrospectively reviewed 9 cases of patients who suffered from primary idiopathic chylopericardium at
our hospital from January 1993 to November 2013.
Results: There were two males and seven females among our patients. Their ages ranged from 13 to 55 years.
The most common clinical presentation was dyspnea. The etiology was idiopathic. All patients were diagnosed
by pericardiocentesis, computed tomography of the chest and lymphoscintigraphy. Non-surgical therapy was
adopted in all nine patients and failed in six, who underwent subsequent successful surgery. Thoracic duct ligation with
the creation of a pericardial window was the most common surgical procedure. All patients were followed up from
3 months to 9 years, and no recurrence occurred.
Conclusions: In assessing patients with an enlarged cardiac silhouette, one should be aware of primary idiopathic
chylopericardium. The most effective treatment is ligation of the thoracic duct and the creation of a pericardial window.
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The accumulation of chyle in the pericardial space, or
chylopericardium, is a condition that occurs most fre-
quently after trauma, cardiothoracic surgery, or radiation
therapy or in association with tumors or tuberculosis.
Congenital lymphangiomatosis or lymphangiectasia may
also be a cause of chylopericardium [1,2]. However, if
the precise etiology cannot be identified, the condition is
called primary or idiopathic chylopericardium, which is
a rare clinical entity. Herein, we report 9 cases of pri-
mary idiopathic chylopericardium and assess the clinical
presentation, etiology, diagnosis, treatment and follow-
up of this entity. A review of the literature is also
presented.* Correspondence: victorm@163.com
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There were ten patients diagnosed with primary idio-
pathic chylopericardium at our hospital between January
1993 and November 2013. One patient was excluded
due to insufficient data. We retrospectively reviewed the
clinical presentation, etiology, diagnosis, treatment and
follow-up of the remaining nine patients. The Ethics Re-
view Committee of Peking Union Medical College Hos-
pital approved this retrospective study. The patient
records/information used in this study were anonymized
and de-identified prior to analysis.Results
The characteristics of the nine patients with primary idio-
pathic chylopericardium are summarized in the Table 1.Clinical presentation and diagnosis
The patient group consisted of two male and seven female
patients with an age range from 13 to 55 years (median age,
36 years). In our cases, the clinical manifestations were vari-
able, including dyspnea (n = 6), a lack of symptoms (n = 2),le distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Table 1 The characteristics of the nine patients with primary idiopathic chylopericardium
Case Year Symptoms Lymphoscintigraphy Non-surgical treatment Surgical treatment Complications Follow-up
1 2000 Dyspnea Communication Pericardiocentesis, MCT diet No No 3 M
2 2002 Dyspnea Communication Pericardiocentesis, MCT diet Right thoracotomy,
L + W
Chylothorax; religation
of the thoracic duct
1 Y
3 2004 Dyspnea Communication Pericardiocentesis, MCT diet,
pericardiostomy
No No 9 Y
4 2004 Atrial fibrillation Pericardial accumulation Pericardiocentesis, MCT diet Right thoracotomy,
L + W
No 6 M
5 2006 Dyspnea Pericardial accumulation Pericardiocentesis, MCT diet Midsternal thoracotomy,
L + W
No 1 Y
6 2006 Dyspnea Pericardial accumulation Pericardiocentesis, MCT diet No No 9 M
7 2008 Dyspnea Negative Pericardiocentesis, MCT diet Right thoracotomy,
L + W
No 2 Y
8 2008 Asymptomatic Negative Pericardiocentesis, MCT diet Right thoracotomy,
L + W
No 8 M
9 2009 Asymptomatic Negative Pericardiocentesis, MCT diet Right VATS,
L + W
No 3 Y
Mmonths, Y years, MCT medium chain triglyceride, VATS video-assisted thoracic surgery, L ligation of the thoracic duct, W pericardial window formation, Communication
communication between the thoracic duct and the pericardial space, Pericardial accumulation pericardial accumulation of technetium-99 m sulfur colloid
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curred. The time from symptom onset to diagnosis was un-
certain (ranging from several months to several years). All
patients denied a history of trauma, congenital heart dis-
ease, thoracic surgery, tuberculosis or thoracic tumors. The
patients underwent a physical examination, routine blood
testing, standard chest radiography, electrocardiography
and thoracic computed tomography (CT). Clinical examin-
ation showed elevated jugular venous pressure and distant
heart sounds. The chest radiograph demonstrated enlarge-
ment of the cardiac silhouette, and echocardiography re-
vealed pericardial effusion. Diagnostic pericardiocentesis
was performed, and milky-colored pericardial fluid was as-
pirated from all patients. These findings, along with the
high level of triglycerides in the pericardial fluid, sufficed to
diagnose chylopericardium. All patients underwent exten-
sive evaluation to find the cause of the chylopericardium.
Routine laboratory tests demonstrated that there was no
sign of a systemic inflammatory reaction. Cultures of the
pericardial fluid for bacteria and tuberculosis were subse-
quently reported as negative, and cytologic examination
showed no tumor cells. A chest CT scan did not reveal me-
diastinal neoplasm, mediastinal lymphadenopathy or other
abnormalities that might have obstructed the thoracic duct.
Lymphoscintigraphy was performed in all patients. Com-
munication between the thoracic duct and the pericardial
space was directly confirmed by lymphoscintigraphy in
three patients. In three cases without communication, peri-
cardial accumulation of technetium-99 m sulfur colloid and
a possible site of leakage from the thoracic duct were con-
firmed. In the other 3 cases without communication, accu-
mulation of technetium-99 m sulfur colloid alone was
found (Figs. 1 and 2).Treatment
Non-surgical treatment
In our patients, non-surgical approaches were adopted
for the treatment of chylopericardium: (1) pericardiocen-
tesis, (2) pericardiostomy, and (3) dietary support with
medium- or short-chain triglycerides and low-fat meals.
Non-surgical treatment continued for approximately 2
to 3 weeks and was effective in 3 patients, in whom
echocardiography showed no increase in pericardial
effusion.
Surgical intervention
Because six patients did not respond adequately to re-
peated pericardiocentesis or continuous drainage of the
pericardial effusion and a diet rich in medium-chain tri-
glycerides (MCTs), surgical treatment was considered.
The surgical procedure consisted of ligation of the thor-
acic duct just above the diaphragm, combined with the
creation of a pericardial window. The surgical approach
adopted was an open procedure in five cases (right pos-
terolateral thoracotomy in four cases, midsternal thoracot-
omy in one case) and right video-assisted thoracoscopy in
one case. The pericardial window was created anterior to
the phrenic nerve to prevent the chylopericardium from
giving rise to cardiac tamponade and further constrictive
pericarditis in the future.
The patients tolerated the procedure well, and no pa-
tients died after the operation. A low-fat diet and initi-
ation of MCTs were requested for no less than two
weeks after the operation.
All of the patients remained stable postoperatively.
The chest tube placed at the time of surgery was re-
moved after the daily drainage decreased to below
Fig. 1 Lymphoscintigraphy. The local images were collected after
injecting Tc-99 m antimony sulfide colloid 5.5 hours. The markedly
increased activity in the areas of the pericardium was seen
Fig. 2 Lymphoscintigraphy. The local images were collected after
injecting Tc-99 m antimony sulfide colloid 20 minutes, 2 and
5.5 hours. Lymphoscintigraphy demonstrates the marked dilatation
of the upper of alimentary duct and the increased uptake in
the pericardium
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operative day. The patients were then discharged, with
their chest X-ray showing a normal cardiac silhouette
and an absence of pleural effusion.
However, one patient (case two in the Table 1) was re-
admitted because copious chylous fluid accumulated in
the right pleural cavity two months later. It was suspected
that the thoracic duct was not completely ligated. There-
fore, a second operation to religate the thoracic duct was
performed using the same approach. In this procedure,
the thoracic duct was exposed between the esophagus,
azygous vein and vertebra and was securely ligated above
the diaphragm. After the second operation, the chylous ac-
cumulation in the pleural cavity was controlled. The dailydrainage decreased to below 100 ml one week later and to
20 ml on the 22nd day postoperatively, after which the
drain was removed. Once a chest X-ray and echocardiog-
raphy showed an absence of pericardial and pleural effu-
sion, the patient was discharged.Follow-up
All patients were followed up from three months to nine
years. There was no recurrence of pericardial effusion,
pleural effusion, cardiac tamponade or constrictive peri-
carditis. Their chest X-ray showed a normal cardiac sil-
houette, or echocardiography showed a lack of pericardial
effusion.Discussion
Chylopericardium is a rare clinical entity in which chyl-
ous fluid accumulates in the pericardial cavity. This en-
tity results from thoracic duct disruption or obstruction,
with both inadequate collateral drainage and reflux of
chylous lymph through the lymphatics draining the heart
and pericardium [3]. Secondary chylopericardium is fre-
quently caused by disruption or obstruction of the thor-
acic duct as a result of thoracic or cardiac surgery, chest
trauma, mediastinal neoplasms, mediastinal tuberculosis,
or mediastinal radiotherapy, and it is occasionally a con-
sequence of thrombosis of the subclavian vein.
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22.6 ml of chyle in the pericardial cavity [4], detected
during the autopsy of a man who had died from as-
phyxia secondary to constriction and tracheal ulceration.
The term “primary chylopericardium” was first used by
Groves and Effler [5], who described a case of isolated
accumulation of chyle in a 31-year-old woman who was
found to have isolated, recurrent accumulation of chyle
in the pericardium associated with mediastinal cystic
hygroma. They used the term “primary idiopathic chylo-
pericardium” in this first case report because no appar-
ent etiologic mechanism was evident.
Primary idiopathic chylopericardium is a rare path-
ology, with very few cases reported to date. From Groves
and Effler’s description in 1954 [5] until 2007, Silva re-
ported that 114 cases of “primary” or “idiopathic” chylo-
pericardium had been described in the literature [6]. We
have found 14 new cases reported since 2007, with a
total of 128 cases described up to November 2013.
Herein, we described nine patients with this clinical en-
tity at our hospital. To the best of our knowledge, this is
the largest case series reported in English to date.
The etiology of chylopericardium is obscure, although
in recent years, several reports have identified lymphatic
leakage and communication with the pericardial sac,
which are visualized by lymphangiography, combined
CT and lymphangiography, or an intraoperative thoracic
ductogram [7]. Damage to the thoracic duct valves, ab-
normal communication between the thoracic duct and
the pericardial lymphatics or abnormally elevated pres-
sure in the thoracic duct and increased permeability of
the lymphatics may represent alternative mechanisms to
explain the pathogenesis of chylopericardium.
Primary idiopathic chylopericardium occurs in all age
groups and affects both sexes equally [8]. The clinical
manifestations may vary from an absence of symptoms
to signs of cardiac tamponade [9,10]. The most common
presentations of patients with chylopericardium are a
lack of symptoms, cough, dyspnea, and fatigue according
to Mask et al. [11].
A chest radiograph showing an enlarged cardiac shadow
is the first step in diagnosis. A cardiac ultrasound follows
to elucidate the cause of cardiomegaly and to confirm the
presence of pericardial fluid. The diagnosis requires an
analysis of the fluid obtained. A milky fluid that contains
fat, high levels of triglycerides and proteins and an ele-
vated lymphocyte concentration confirms the diagnosis of
chyle accumulation [11,12].
When the diagnosis of chylopericardium has been estab-
lished, a search for the underlying cause should be per-
formed. Exclusion of a history of trauma caused by thoracic
surgery or blunt injury is needed. The introduction of sub-
clavian venous catheters or episodes of vomiting or violent
coughing should be noted [13]. Investigations specificallyfocused on detecting malignant disease, lymphoma, and tu-
berculosis should be conducted. A CT scan or MRI may
then be performed to exclude lymphatic obstruction caused
by a mass. Tuberculosis could be excluded using cultures
and microscopic examination of the pericardial fluid.
Lymphangiography may demonstrate the presence of com-
munication between the pericardial sac and the lymphatic
system in certain cases [7]. If no obvious cause can be
established, the entity is labeled “primary idiopathic
chylopericardium.”
In our cases, we excluded the common causes of chy-
lopericardium. For this reason, we concluded that these
patients should be diagnosed with primary idiopathic
chylopericardium. One of our patients did have a his-
tory of treatment for tuberculosis, but there was no
clinical or other evidence of pulmonary tuberculosis
upon investigation.
The management of chylopericardium is centered on
the prevention of the mechanical (cardiac tamponade or
constructive pericarditis), metabolic and immunological
consequences of chylopericardium and seeks to elimin-
ate lymphatic fluid losses and to reduce recurrence. Ini-
tially, patients should be treated with non-surgical
measures, such as (1) pericardiocentesis; (2) pericardial
drainage; (3) dietary support with a low-fat diet and ini-
tiation of MCTs, which are absorbed via the portal vein,
rather than via the lymphatic vessels, or even with total
parenteral nutrition; and (4) pharmacological therapy
with octreotide, which has been shown to reduce intes-
tinal absorption of fats [14].
Non-surgical treatment of idiopathic chylopericardium is
usually not satisfactory, and a failure rate of 57 to 60 % has
been reported [1,15]. Rusca reported that medical therapy
should not be continued for longer than two weeks [16]. If
medical therapy proves to be ineffective, then surgical treat-
ment should be considered, even in asymptomatic patients,
to avoid subsequent progression to cardiac tamponade or
constrictive pericarditis [17].
There are different approaches to the surgical treatment
of chylopericardium: (1) pericardiectomy, (2) pericardial
window formation, and (3) ligation of the thoracic duct
above the level of the diaphragm. Pericardiectomy is per-
formed to ensure complete drainage and to prevent later
constrictive pericarditis. Pericardial window formation
alone is simple but carries a high incidence of recurrence
because it does not close the communication between the
thoracic duct and the pericardial sac [1,15]. The necessity
of thoracic duct ligation is well illustrated by a case re-
ported by Musemeche and associates [18], wherein partial
pericardiectomy and the creation of a pericardial window
without thoracic duct ligation were followed by continued
chylous leakage. After a second operation with ligation of
the thoracic duct, the drainage abruptly ceased. Akamatsu
et al. [1] reviewed 79 cases described in the literature up to
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treated, with 41 (52 %) undergoing ligation plus resection
of the thoracic duct associated with pericardial window for-
mation. According to these reports, thoracic duct ligation
and pericardial window formation are believed to be the
most effective procedures to prevent recurrence.
The thoracic duct, especially in the lower thoracic cav-
ity, is accessible during surgery from either the right or
the left side. Most researchers believe that the left-sided
approach has certain disadvantages. In the lower thor-
acic cavity, the thoracic duct is located between the azy-
gous vein and the descending aorta. The heart and the
descending aorta hinder the exposure of the duct from
the left side. It is easy to access the duct when entering
from the right hemithorax.
Furrer and Nikolaos performed duct ligation and peri-
cardial window formation by means of right-sided thora-
coscopy [19,20]. The identification and ligation of the
thoracic duct from a low position are no different from
the methods used in traditional surgery. As thoraco-
scopic surgery is much less invasive than conventional
open surgery and leaves minimal scarring, we recom-
mend a right-sided thoracoscopic approach to the thor-
acic duct in the lower thoracic cavity.
For a patient who refuses surgical treatment but who ex-
hibits continuous pericardial effusion, pericardio-peritoneal
shunt placement [21] or thoracic duct embolization (TDE)
[22] may be a simple and effective alternative.
As cardiac tamponade, constructive pericarditis or recur-
rence may occur, patients with chylopericardium should be
regularly followed. In our cases, all patients were well,
with no complaints, when they were followed up from
three months to nine years. Thus, we believe that the
outcomes of all of our patients were favorable, despite
one patient having undergone two operations.
Conclusions
In summary, primary idiopathic chylopericardium is a rare
condition. It should be included in the differential diagnosis
of a patient presenting with an enlarged cardiac silhouette.
The patient should be evaluated rapidly to prevent the
complications of this disease. We recommend a brief trial
of medical therapy for no longer than three weeks, followed
by thoracic duct ligation and pericardial window formation
by right-sided thoracoscopy if this therapy fails. Dietary
restriction needs to be continued following surgical
therapy. All patients should be followed up for a long
period of time.
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